Caitlin John »

Halozyme Therapeutics shares owned by Caitlin John

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Caitlin John from 13F filings

Historical chart of Caitlin John investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Caitlin John consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Caitlin John

Quarter filed Position value Share count Share price at filing
2025-12-31 $465k 6.9k 67.30

More positions owned by Caitlin John

Spdr Series Trust State Street Spd (BIL)
Schwab Strategic Tr 5 10yr Corp Bd (SCHI)
Spdr Series Trust State Street Spd (SPLB)
Spdr Series Trust State Street Spd (SPHY)
Spdr Series Trust State Street Spd (SPSB)
Spdr Series Trust State Street Spd (SPTL)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Silver Tr Ishares (SLV)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust State Street Spd (BILS)
World Gold Tr Spdr Gld Minis (GLDM)
Spdr Gold Tr Gold Shs (GLD)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Microsoft Corporation (MSFT)
Ishares Msci Eurzone Etf (EZU)

View all positions for Caitlin John

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics